Grant MSc - Catalyst Biosciences Chief Officer
| CBIODelisted Stock | USD 0.41 0.02 4.65% |
Insider
Grant MSc is Chief Officer of Catalyst Biosciences
| Phone | 650 871 0761 |
| Web | https://www.catalystbiosciences.com |
Catalyst Biosciences Management Efficiency
The company has return on total asset (ROA) of (0.3824) % which means that it has lost $0.3824 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6901) %, meaning that it created substantial loss on money invested by shareholders. Catalyst Biosciences' management efficiency ratios could be used to measure how well Catalyst Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Catalyst Biosciences currently holds 38 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Catalyst Biosciences has a current ratio of 18.48, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Catalyst Biosciences' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 10 records | INSIDER Age | ||
| Alexander Klibanov | Pulmatrix | 74 | |
| Miles Nunn | Akari Therapeutics PLC | 55 | |
| Annie Mack | Akari Therapeutics PLC | N/A | |
| Craig Lewis | Benitec Biopharma Ltd | N/A | |
| Ray MD | Akari Therapeutics PLC | 79 | |
| Margaret MD | Pulmatrix | 67 | |
| Torsten Hombeck | Akari Therapeutics PLC | 54 | |
| Aidan Curran | Pulmatrix | N/A | |
| Melissa BradfordKlug | Akari Therapeutics PLC | 54 | |
| MBA CMA | Pulmatrix | 69 | |
Management Performance
| Return On Equity | -2.69 | |||
| Return On Asset | -0.38 |
Catalyst Biosciences Leadership Team
Elected by the shareholders, the Catalyst Biosciences' board of directors comprises two types of representatives: Catalyst Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Catalyst. The board's role is to monitor Catalyst Biosciences' management team and ensure that shareholders' interests are well served. Catalyst Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Catalyst Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nassim Usman, CEO and President and Director | ||
| Ana Kapor, Sr Communications | ||
| Tom DVM, Sr Devel | ||
| Seline CPA, Interim Fin | ||
| Grant MSc, Chief Officer |
Catalyst Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Catalyst Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.69 | |||
| Return On Asset | -0.38 | |||
| Current Valuation | 51.03 M | |||
| Shares Outstanding | 37.97 M | |||
| Shares Owned By Insiders | 27.73 % | |||
| Shares Owned By Institutions | 8.75 % | |||
| Number Of Shares Shorted | 34.05 K | |||
| Price To Earning | (0.34) X | |||
| Price To Book | 0.53 X | |||
| Price To Sales | 4.82 X |
Pair Trading with Catalyst Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalyst Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Catalyst Stock
| 0.9 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.88 | HYMTF | Hyundai Motor | PairCorr |
| 0.87 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.85 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.81 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Catalyst Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catalyst Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catalyst Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catalyst Biosciences to buy it.
The correlation of Catalyst Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catalyst Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catalyst Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Catalyst Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Catalyst Stock
If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |